Zdrowie i gospodarka · 01/09/2016
FDA Renews Endocrinologic and Metabolic Drugs Advisory Committee for 2 Years
The FDA has renewed the Endocrinologic and Metabolic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on August 27, 2018.